Australia markets closed

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.79-0.06 (-0.40%)
At close: 04:00PM EDT
14.79 0.00 (0.00%)
After hours: 04:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.45B
Enterprise value 2.04B
Trailing P/E N/A
Forward P/E 30.96
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.01
Price/book (mrq)5.29
Enterprise value/revenue 2.51
Enterprise value/EBITDA 336.57

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 3-38.91%
S&P500 52-week change 326.36%
52-week high 333.99
52-week low 314.65
50-day moving average 317.74
200-day moving average 323.53

Share statistics

Avg vol (3-month) 31.9M
Avg vol (10-day) 32.24M
Shares outstanding 5165.22M
Implied shares outstanding 6168.22M
Float 8107.79M
% held by insiders 10.49%
% held by institutions 1100.95%
Shares short (30 Apr 2024) 412.03M
Short ratio (30 Apr 2024) 48.46
Short % of float (30 Apr 2024) 49.85%
Short % of shares outstanding (30 Apr 2024) 47.28%
Shares short (prior month 28 Mar 2024) 411.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.21%
Operating margin (ttm)7.39%

Management effectiveness

Return on assets (ttm)-0.38%
Return on equity (ttm)-0.41%

Income statement

Revenue (ttm)813.81M
Revenue per share (ttm)4.95
Quarterly revenue growth (yoy)73.80%
Gross profit (ttm)N/A
EBITDA 6.07M
Net income avi to common (ttm)-1.71M
Diluted EPS (ttm)0.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)470.52M
Total cash per share (mrq)2.85
Total debt (mrq)59.64M
Total debt/equity (mrq)12.85%
Current ratio (mrq)2.04
Book value per share (mrq)2.81

Cash flow statement

Operating cash flow (ttm)63.71M
Levered free cash flow (ttm)34.42M